These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30498313)

  • 1. Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study.
    Garg N; Kotru M; Kumar D; Pathak R; Sikka M
    J Lab Physicians; 2018; 10(4):410-413. PubMed ID: 30498313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
    Suggs JL; Cruse JM; Lewis RE
    Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis.
    Eren R; Aslan C; Yokuş O; Doğu MH; Suyani E
    Mol Clin Oncol; 2016 Aug; 5(2):331-332. PubMed ID: 27446573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
    Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
    J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
    Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
    Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
    Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunophenotype of adult T acute lymphoblastic leukemia in Morocco.
    Lahjouji A; Bachir F; Bennani S; Quessar A; Amzazi S
    Exp Oncol; 2015 Mar; 37(1):64-9. PubMed ID: 25804235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of flow cytometry in the differential diagnosis of lymphoma/leukemia with aberrant antigen expression].
    Xia CQ; Chen SL; Qi M; Xu XF
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):532-5. PubMed ID: 15634450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining an Optimal Number of Immunophenotypic Markers for Lineage Assignment of Acute Leukemias Based on the EGIL Scoring System.
    Lee ST; Kim HJ; Kim SH
    Korean J Lab Med; 2006 Dec; 26(6):393-9. PubMed ID: 18156757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
    Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
    Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of subtypes and immunophenotypic characterization of 1379 cases of paediatric acute leukaemia.
    Jamal S; Meraj F; Mansoor N; Parveen S; Shaikh A; Jabbar N
    Pak J Med Sci; 2021; 37(3):805-811. PubMed ID: 34104169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
    Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
    Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.